GRACE :: Lung Cancer

Subject Archives
General (50)
GRACEcast (58)
- Webinars (25)
Lung Cancer (568)
- A Reference Library on Lung Cancer (10)
- ALK inhibition (1)
- Clinical Cases (26)
- Core Concepts (184)
  - Bronchioloalveolar Carcinoma (BAC) (18)
  - Early Stage NSCLC & Surgery (35)
  - Locally Advanced (Stage III) NSCLC (24)
  - Maintenance Therapy after First Line (3)
  - Metastatic/Recurrent NSCLC, First Line (38)
  - Metastatic/Recurrent NSCLC, Second Line and Later (25)
  - Never-Smokers with Lung Cancer (12)
  - SCLC, Extensive Disease and Recurrent (13)
  - SCLC, Limited Disease (8)
  - Targeted Therapies, Activity and Side Effects (47)
  - What I Really Do (16)
- Current Clinical Trials (59)
- General Lung Cancer Issues (502)
  - Causes of Lung Cancer & Prevention Strategies (19)
  - Evaluation and Work-Up (36)
  - Gene Profiles/Molecular Signatures (32)
  - Imaging and Response Measurement (24)
  - Management of Bone Metastases (3)
  - Management of Brain Metastases (14)
  - Management of Pleural Effusions (3)
  - Miscellaneous Other Problems from Lung Cancer (9)
  - never-smoker NSCLC (40)
  - Pathology/Lung Cancer Subtypes (41)
  - Screening Issues and Controversy (13)
  - Smoking Cessation/Tobacco Control (12)
  - Supportive care (7)
  - Treatment (403)
    - Chemotherapy (197)
    - Radiation therapy (57)
    - Surgery Issues (61)
    - Targeted therapies (240)
      - Anti-angiogenic agents (51)
      - Epidermal growth factor receptor (EGFR)-based therapies (176)
        
        Clinical variables in EGFR therapy (43)
        
        EGFR mutations and other molecular markers (88)
        
        Rash and other side effects (15)
      - Immune/Vaccine-based therapies (5)
      - Multikinase inhibitors (17)
      - Other targeted therapies (19)
- Mesothelioma (7)
- Non-Small Cell Lung Cancer (NSCLC) (375)
  - Early Stage NSCLC (Stage I/II) (65)
  - Stage III/Locally Advanced NSCLC (84)
    - Resectable locally advanced NSCLC (44)
    - Unresectable locally advanced NSCLC (39)
  - Stage IV/Advanced/Metastatic NSCLC (246)
    - First-line treatment (157)
    - Maintenance therapy (4)
    - Second-line treatment (113)
    - Third-line therapy and beyond (59)
- Small Cell Lung Cancer (SCLC) (50)
  - Extensive Disease Small Cell Lung Cancer (ED-SCLC) (39)
  - Limited Disease Small Cell Lung Cancer (LD-SCLC) (17)
- Special Populations in Lung Cancer (101)
  - Bronchioloalveolar Carcinoma (BAC) (33)
  - Never-smokers with lung cancer (33)
  - Older and/or frail patients with lung cancer (27)
  - Pancoast Tumors (5)
  - Sex-based differences in lung cancer (12)

Recent Posts

Posted In

Uncategorized